Crystal structure study and investigation of solid-state cyclization for AMG 222, a channel hydrate

Add time:07/23/2019    Source:sciencedirect.com

In this study, we investigate the solid-state structure and stability of AMG 222 (5-(2-[2-(2-cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-propyl)-5-(1H-tetrazol-5-yl)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene-2,8 dicarboxylic acid bisdimethylamide), a small molecule DPP-IV inhibitor. Crystal structure of AMG 222 has been solved from single crystal X-ray analysis. Crystallographic data are as follows: monoclinic, P21 (no. 4), a = 9.0327(5) Å, b = 18.6177(8) Å, c = 21.4927(10) Å, β = 90.126(3)°, V = 3614.4(3) Å3, Z = 4. Based on single crystal structure, AMG 222 is a pentahydrate with the water molecules sitting in channels formed by the drug framework. There are three distinct crystal structures of AMG 222 between 0 and 95% relative humidity (RH), namely the anhydrate, hemihydrate, and pentahydrate forms. Solid-state stability of the GMP batch showed a high level of cyclized degradation product. It was postulated that the degradation was promoted by increased amorphous content generated as a result of excessive drying that was employed to remove residual crystallization solvent. Material produced using a modified procedure using a humidified nitrogen purge had lower amorphous content and lower levels of cyclic degradation when compared to the GMP batch.

We also recommend Trading Suppliers and Manufacturers of 5H-dibenzo(a,d)cycloheptene-10,11-oxide (cas 16145-11-2). Pls Click Website Link as below: cas 16145-11-2 suppliers

Prev:Synthesis of dibenzo[a,d]cycloheptanes as cytokine biosynthesis inhibitors
Next:Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity)